Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-07-27, Stock:JNJ, The news for the past five days is as follows:
2021-07-20: NEWS1: Drug Distributors Reach $1.2 Billion Opioid Settlement with New York State.NEWS2: Stock market news live updates: Futures inch higher after big rally, COVID remains focus.NEWS3: J&J Shot Is Less Effective Against Delta Variant Vs. Original Strain: New Study.NEWS4: Stock market news live updates: Stocks claw back prior day’s losses, post gains of nearly 2% in bargain-hunting rally as COVID fears wane.NEWS5: Drug Stocks Pop On Reports Of $26 Billion Settlement In Opioid Fight.NEWS6: JNJ Option Traders Ready for Positive Earnings.NEWS7: ‘Likelihood of reaching herd immunity at this point is fairly low’: Epidemiologist.NEWS8: 10 Cheap Monthly Dividend Stocks to Buy Now.NEWS9: Opioid settlement nears $26 billion, Judge allows vaccine mandate at university, Israeli PM threatens Unilever.NEWS10: Drug Stocks McKesson, AmerisourceBergen Pop On Reports Of $26 Billion Settlement In Opioid Fight.NEWS11: J&J, Distributors Near Final Opioid Deal Terms With States.NEWS12: Why Earnings Season Could Be Great for J&J (JNJ).NEWS13: Have $1,000? 2 Stocks to Buy Before the Next Market Crash.NEWS14: Vaccine Makers Gain After Fox News Anchors Become Jab Supporters.NEWS15: Opioid Settlement Of $26B Between Drug Companies, States To Potentially Conclude This Week.NEWS16: Johnson & Johnson, 3 Drug Distributors Near $26B Opioid Accord.NEWS17: IBM, Apple and Halliburton Rise Premarket; PPG Falls.NEWS18: J&J, Drug Distributors Up As Opioid Case Nears $26 Billion Settlement.NEWS19: U.S. states to unveil $26 billion opioid settlement with drug distributors, J&J - sources.
2021-07-21: NEWS1: South African company to start making Pfizer vaccine.NEWS2: States Unveil $26 Billion Settlement Over Opioid Lawsuits.NEWS3: Stock market news live updates: Futures gain after 2 day rally, eyes on jobless claims.NEWS4: J&J, Distributors Unveil $26 Billion Opioid Deal With States.NEWS5: Dow Jones Up 270 Points After Coca-Cola, Johnson & Johnson, Verizon Announce Earnings.NEWS6: Dow closes up more than 285 points as stocks extend rebound rally.NEWS7: Johnson & Johnson (JNJ) Q2 2021 Earnings Call Transcript.NEWS8: J&J Nabs $5 Billion Opioid Settlement And Beats Second-Quarter Views.NEWS9: Why Shares of Endo Pharamecuticals Are Soaring Today.NEWS10: Is JNJ Stock A Buy Or A Sell As Delta Question Plagues Covid Shot?.NEWS11: J&J Shrugs Off Vaccine Worries And Nabs Opioid Settlement — Will Shares React?.NEWS12: J&J to stop selling opioids for 10 years and will pay $5 billion as part of settlement.NEWS13: State AGs urge support for landmark $26 billion opioid settlement.NEWS14: UPDATE 6-U.S. state officials urge support for landmark $26 bln opioid settlement.NEWS15: Catalent Plans $100M Expansion Of Biologics Capabilities At Italian Vaccine Plant.NEWS16: U.S. state officials urge support for landmark $26 billion opioid settlement.NEWS17: Johnson & Johnson's COVID-19 Shot Is Less Effective Against Delta Variant: Study.NEWS18: ‘It’s very premature to talk about booster vaccines’: Doctor.NEWS19: Delta variant of SARS-CoV-2 will likely be dominant strain globally within months after spreading to 124 countries, says WHO.NEWS20: Dow Jones Rallies As Netflix Slides On Earnings; Chipotle Surges On Earnings Beat.NEWS21: Stocks End Higher as Wall Street Turns Focus to Corporate Earnings.NEWS22: J&J CFO: Not-for-Profit Vaccine Price Likely to End in 2021.NEWS23: J&J COVID-19 vaccine sales to total  $2.5 billion in 2021.NEWS24: Dow up more than 200 points as stocks extend rebound rally.NEWS25: U.S. Corporate Earnings Cast Off Covid Gloom With Rosy Outlooks.NEWS26: Norway, Lithuania swap J&J, Pfizer vaccines to speed up inoculation.NEWS27: Delta variant of COVID is now in 124 countries and will likely be dominant strain globally within months, says WHO.NEWS28: Stocks Trade Higher as Wall Street Turns Focus to Corporate Earnings.NEWS29: US STOCKS-Wall Street rises on upbeat earnings, recovery optimism.NEWS30: Coke, J&J, Verizon All Beat on Q2 Numbers.NEWS31: Earnings Strength From J&J, Chipotle, Coca-Cola Helps Set Positive Early Tone.NEWS32: Dow Jones Today Leads As Stocks Extend Rebound; Earnings Lift Chipotle, ASML Holdings; China Floods Weigh On Apple.NEWS33: Johnson & Johnson Shrugs Off Vaccine Worries But Stays Flat Despite Quarterly Beat.NEWS34: J&J Earnings Beat Expectations as Study Raises Doubts Over Vaccine’s Efficacy.NEWS35: Earnings Data Deluge.NEWS36: Dow opens higher as stocks extend rebound rally.NEWS37: J&J (JNJ) Beats on Q2 Earnings & Sales, Ups View, Stock Rises.NEWS38: JNJ CFO: We’re certain vaccine demand will increase.NEWS39: Dow Jones Today, Futures Seek Balance After Rebound; Earnings Lift Chipotle, ASML Holdings; Will China Floods Hurt Apple?.NEWS40: J&J Stock Rises on Earnings.  Study Adds to Doubts Over Its Vaccine’s Efficacy..NEWS41: Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates.NEWS42: Dow futures up 140 points as stocks aim to extend rebound.NEWS43: US STOCKS-Upbeat earnings, recovery optimism lift Wall St futures.NEWS44: Stocks Extend Gains as Wall Street Turns Focus to Corporate Earnings.NEWS45: J&J forecasts $2.5 billion in 2021 COVID-19 vaccine sales, sets lower production target.NEWS46: Johnson & Johnson beats earnings estimates for Q2 and raises full-year guidance.NEWS47: UPDATE 5-J&J forecasts $2.5 bln in 2021 COVID-19 vaccine sales, sets lower production target.NEWS48: Johnson & Johnson Earnings Beat Views, Dow Giant Raises Full-Year Guidance.NEWS49: J&J raises revenue forecast, estimates $2.5 billion in COVID-19 vaccine sales.NEWS50: Coronavirus tally: Global cases of COVID-19 top 191.4 million and study finds J&J vaccine less effective vs. delta variant.NEWS51: Johnson & Johnson Reports Q2 2021 Results.NEWS52: Drugmakers, pharmacies next targets for U.S. opioid settlements.NEWS53: Video: Jim Cramer on Chipotle, J&J, Netflix, FAANG, Bed Bath & Beyond.NEWS54: Live: Jim Cramer on Chipotle, J&J, Netflix, FAANG, Bed Bath & Beyond.NEWS55: Stocks Extend Gains as Focus for Wall Street Is on Earnings.NEWS56: Premarket Movers Wednesday: Chembio, NeuroMetrix, Johnson & Johnson.NEWS57: Netflix Falls Premarket; Coca-Cola, Verizon and Chipotle Rise.NEWS58: J&J Gains On Revising Guidance After Medical Devices Boost In Q2.NEWS59: Johnson & Johnson Beats Earnings Forecast; Vaccine Sales Top $160 Million.
2021-07-22: NEWS1: Coronavirus: ‘Defiance’ led to U.S. 600,000 deaths, physician says.NEWS2: UPDATE 1-U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports.NEWS3: ‘We haven’t seen the high consequence variants yet’: Doctor.NEWS4: Here's How to Find the Best Dividend Stocks.NEWS5: Why the Delta variant is so dangerous for the unvaccinated.NEWS6: UPDATE 1-EU has shipped tiny percentage of planned COVID-19 shot donations - document.NEWS7: JNJ Beats on Q2 Earnings, Ups View: ETFs to Buy.NEWS8: US States Get $26B Settlement Deal in Opioid Abuse Litigation.NEWS9: Stocks Now Up for the Week After Second Day of Gains.NEWS10: 10 Best Monthly Dividend Stocks with High Yields.NEWS11: Portnoy Law: Lawsuit Filed On Behalf of Johnson & Johnson Consumer, Inc. Investors.NEWS12: How Big of an Impact Will COVID-19 Have on the Stock Market Going Forward?.NEWS13: UPDATE 2-Africa demands local production of COVID vaccines.NEWS14: What You Should Know About Johnson & Johnson's Newest COVID Vaccine Warning.NEWS15: EU has shipped tiny percentage of planned COVID-19 shot donations - document.NEWS16: Africa to start receiving 400 mln J&J COVID-19 vaccine doses next week.
2021-07-23: NEWS1: Stock Market Rally Rebounds To Highs; Snap, Crocs, Chipotle, Netflix Are Key Earnings.NEWS2: COVID SCIENCE-J&J shot recipients may need a booster; new advice on infected kids.NEWS3: Top Research Reports for Johnson & Johnson, Oracle & SAP.NEWS4: Doctor on the Olympics regarding COVID-19: ‘There are a lot of concerns’.NEWS5: 10 Best Dividend Contenders to Buy in 2021.NEWS6: This is the tipping point for when people vaccinated against COVID-19 should mask up again indoors.NEWS7: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Johnson & Johnson (NYSE:JNJ) Investigation.NEWS8: Pharma Stock Roundup: JNJ, NVS Q2 Earnings, PFE, ABBV, LLY & MRK FDA Updates.NEWS9: The Big Winner With Johnson & Johnson's Recent FDA Approval.NEWS10: Can Today's Vaccines Beat the Delta Variant?.
2021-07-26: NEWS1: Doctor on COVID-19 vaccination: ‘Too little too late, better late than never, if anything it all counts’.NEWS2: Ocugen CEO on vaccine hesitancy in the U.S..NEWS3: JNJ Option Traders Aim to Continue Positive Trend.NEWS4: UPDATE 1-Aspen to start J&J COVID-19 vaccine supplies to South Africa from Monday.NEWS5: Aspen to start supplies of J&J COVID-19 vaccine to South Africa from Monday.

Answer: Rise